Apollo Hospitals share price jumps over 4% 50 52-week high on plans to list digital health, pharmacy businesses
The board of directors of Apollo Hospitals Enterprise and Apollo HealthCo, a subsidiary of the healthcare major, have accorded in-principle approval for the composite scheme of arrangement.
The scheme entails the demerger of the Omni Channel Pharma and Digital Health business - comprising the telehealth business of Apollo and its investment in Apollo HealthCo Ltd - into a new entity.
Following the demerger, the scheme provides for the amalgamation of Apollo HealthCo with the new entity.
This will subsequently be followed by the amalgamation of Keimed Pvt Ltd with NewCo (new entity).
'The proposed transaction will result in the creation of the largest, integrated omni-channel healthcare eco-system with a FY25 revenue of ₹ 16,300 crores ($1.9 billion) in FY25,' Apollo Hospitals said in a release.
The business will comprise - Apollo 24/7, the digital health platform; the offline pharma distribution of AHL; Third party pharma distribution of Keimed; and telehealth services of AHEL.
'The combination of businesses is anticipated to generate substantial synergies, and the New Co is expected to achieve a revenue run rate of ₹ 25,000 crores ($2.9 billion) by FY27,' the company added.
Upon the effectiveness of the Scheme, the new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges, it added.
The listing is expected within 18-21 months, the healthcare major said.
For every 100 shares of Apollo Hospitals Enterprise, the shareholders of Apollo Hospitals Enterprise will receive 195.2 shares of NewCo, enabling their direct participation in the value unlock.
Upon becoming an IOCC, the entity also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5% stake in Apollo Medicals Pvt Ltd (AMPL), which owns 100% of Apollo Pharmacies Limited (APL), it said.
Apollo Hospitals Enterprise will retain a 15% stake in the 'NewCo' to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle, it added.
Apollo Hospitals Enterprise MD Suneeta Reddy said the proposal enables the healthcare provider's shareholders to gain direct shareholding to country's largest omni-channel pharmacy and digital health platform.
Apollo Hospitals share price has risen 9% in one month, and more than 12% in three months. The stock is up just 1% on a year-to-date (YTD) basis, but has rallied 22% in one year. Apollo Hospitals shares have delivered mutlibagger returns of 466% in the past five years.
At 10:15 AM, Apollo Hospitals share price was trading 3.28% higher at ₹ 7,480.00 apiece on the BSE.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
Crizac IPO opens today: Check GMP, price band, and other details
Crizac's Rs 860 crore IPO opens today with the issue entirely comprising an offer-for-sale of 3.51 crore equity shares in the price band of Rs 233–245 apiece. The IPO will close on July 4 and the company is expected to list on the BSE and NSE on July 9. Ahead of the issue opening, the GMP is 9% over the issue price. Incorporated in 2011, Crizac operates a B2B international education platform that connects universities from the UK, Canada, Ireland, Australia, and New Zealand with global student recruitment agents. It sources student applications from over 75 countries via a proprietary technology platform, leveraging a network of more than 10,000 registered agents. The company has shown explosive growth, with total income rising from Rs 274 crore in FY23 to Rs 849 crore in FY25 — a CAGR of 76%. PAT jumped from Rs 110 crore to Rs 152 crore over the same period, with FY25 earnings per share at Rs 8.74 and net margins of 18%. Crizac operates debt-free and has strong cash flows, indicating a healthy balance sheet. At the upper end of the price band, the issue is valued at a P/E of 28x FY25 earnings and P/B of 9x, placing it roughly in line with its only comparable listed peer, IndiaMART , which trades at similar multiples. The lot size for retail investors is 61 shares, requiring a minimum investment of Rs 14,945. High net-worth investors must apply for a minimum of 14 lots (854 shares), translating to Rs 2.09 lakh. Review: Robust fundamentals meet global growth story Analysts said Crizac is uniquely positioned to benefit from the sustained outflow of Indian students to foreign universities, a market expected to touch 2.5 million students by 2030. Its B2B model, focus on Tier-1 geographies, and scalable tech infrastructure make it a rare listed play in the international education facilitation space. However, investors must weigh the regulatory risks. The UK and Canada, Crizac's largest markets, have recently tightened student visa norms — a trend that could pressure future revenue growth. "Crizac combines digital platform scale, a rising global education trend, and disciplined financial performance — elements that long-term investors typically prize. Subscribe for long-term gains," said Canara Bank Securities.
Economic Times
39 minutes ago
- Economic Times
Crizac IPO opens today: Check GMP, price band, and other details
Crizac's Rs 860 crore IPO opens today with the issue entirely comprising an offer-for-sale of 3.51 crore equity shares in the price band of Rs 233–245 apiece. The IPO will close on July 4 and the company is expected to list on the BSE and NSE on July 9. ADVERTISEMENT Ahead of the issue opening, the GMP is 9% over the issue price. Incorporated in 2011, Crizac operates a B2B international education platform that connects universities from the UK, Canada, Ireland, Australia, and New Zealand with global student recruitment agents. It sources student applications from over 75 countries via a proprietary technology platform, leveraging a network of more than 10,000 registered company has shown explosive growth, with total income rising from Rs 274 crore in FY23 to Rs 849 crore in FY25 — a CAGR of 76%.PAT jumped from Rs 110 crore to Rs 152 crore over the same period, with FY25 earnings per share at Rs 8.74 and net margins of 18%. Crizac operates debt-free and has strong cash flows, indicating a healthy balance sheet. ADVERTISEMENT At the upper end of the price band, the issue is valued at a P/E of 28x FY25 earnings and P/B of 9x, placing it roughly in line with its only comparable listed peer, IndiaMART, which trades at similar multiples. The lot size for retail investors is 61 shares, requiring a minimum investment of Rs 14,945. High net-worth investors must apply for a minimum of 14 lots (854 shares), translating to Rs 2.09 lakh. ADVERTISEMENT Review: Robust fundamentals meet global growth storyAnalysts said Crizac is uniquely positioned to benefit from the sustained outflow of Indian students to foreign universities, a market expected to touch 2.5 million students by 2030. Its B2B model, focus on Tier-1 geographies, and scalable tech infrastructure make it a rare listed play in the international education facilitation space. ADVERTISEMENT However, investors must weigh the regulatory risks. The UK and Canada, Crizac's largest markets, have recently tightened student visa norms — a trend that could pressure future revenue growth."Crizac combines digital platform scale, a rising global education trend, and disciplined financial performance — elements that long-term investors typically prize. Subscribe for long-term gains," said Canara Bank Securities. ADVERTISEMENT (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
an hour ago
- Time of India
Sambhv Steel Tubes IPO to list today. GMP signals healthy debut
Sambhv Steel Tubes is set to debut on the BSE and NSE on Wednesday amid early signs of healthy investor interest . The company's IPO, priced at Rs 82 per share, is commanding a GMP of Rs 14 on the eve of its listing, indicating a likely listing price of around Rs 96. This translates to a potential listing gain of over 17%. The Rs 540 crore public issue , comprising a fresh issue of Rs 440 crore and an offer for sale of Rs 100 crore, received robust demand during the bidding window from June 24 to 27. The IPO was subscribed across all investor categories, with particular strength seen in the institutional and high-net-worth segments. Market participants say the premium in the unofficial market reflects investor confidence in the company's business model and financial performance. Sambhv Steel is India's only single-location backward-integrated ERW pipe and steel tubes manufacturer, and operates out of Chhattisgarh. The company produces sponge iron, hot rolled coils, and galvanized pipes under one roof, giving it operational and cost advantages in a competitive sector. The company also benefits from proximity to major raw material sources, including coal and iron ore mines run by public sector undertakings, and services clients across 15 Indian states. Its widespread distribution network and diversified product portfolio have helped it post consistent revenue growth over the last three financial years. Live Events Analysts tracking the issue say Sambhv's integrated operations, rising infrastructure demand , and post-issue debt reduction strategy make the stock attractive in the medium to long term. The IPO raised Rs 161 crore from anchor investors ahead of the public offering, further bolstering sentiment. The allotment was finalized on June 30, and equity shares are expected to be credited to demat accounts ahead of the listing. Sambhv's listing performance will be closely watched as a barometer of investor appetite for midcap industrial plays amid broader market volatility. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) ETMarkets WhatsApp channel )
